This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
BBS-Bioactive Bone Substitutes Oyj Management
Management criteria checks 1/4
Key information
Ilkka Kangasniemi
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 3.4yrs |
CEO ownership | n/a |
Management average tenure | 2yrs |
Board average tenure | 2.6yrs |
Recent management updates
Recent updates
CEO
Ilkka Kangasniemi (58 yo)
3.4yrs
Tenure
Prof. Ilkka Kangasniemi, Ph D., Ass. Prof., is the Chief Executive Officer at BBS-Bioactive Bone Substitutes Oyj since October 15, 2019. Prof. Kangasniemi served as Chief Scientific Officer of Vivoxid Ltd....
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Executive Officer | 3.4yrs | no data | no data | |
Chief Financial Officer | less than a year | no data | no data | |
Chief Commercial Officer & Member of Advisory Board | 3.8yrs | no data | no data | |
Head of Production | less than a year | no data | no data |
2.0yrs
Average Tenure
Experienced Management: BONES's management team is considered experienced (2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Commercial Officer & Member of Advisory Board | no data | no data | no data | |
Independent Chairman of the Board | 6.8yrs | no data | 0.26% € 327.7k | |
Director | 1.9yrs | no data | no data | |
Director | 20.2yrs | no data | 5.7% € 7.1m | |
Member of Advisory Board | no data | no data | no data | |
Member of Advisory Board | no data | no data | no data | |
Member of Advisory Board | no data | no data | no data | |
Member of Advisory Board | no data | no data | no data | |
Independent Director | 2.6yrs | no data | no data | |
Independent Director | less than a year | no data | no data |
2.6yrs
Average Tenure
66yo
Average Age
Experienced Board: BONES's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.